1. Home
  2. CGAU vs TXG Comparison

CGAU vs TXG Comparison

Compare CGAU & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centerra Gold Inc.

CGAU

Centerra Gold Inc.

HOLD

Current Price

$18.05

Market Cap

2.4B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$22.02

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGAU
TXG
Founded
2002
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CGAU
TXG
Price
$18.05
$22.02
Analyst Decision
Buy
Hold
Analyst Count
3
14
Target Price
$14.17
$15.61
AVG Volume (30 Days)
1.1M
2.3M
Earning Date
02-19-2026
02-11-2026
Dividend Yield
1.24%
N/A
EPS Growth
236.39
N/A
EPS
1.60
N/A
Revenue
$1,285,392,000.00
$641,814,000.00
Revenue This Year
$14.70
$4.91
Revenue Next Year
$12.63
N/A
P/E Ratio
$10.10
N/A
Revenue Growth
2.66
1.92
52 Week Low
$5.41
$6.78
52 Week High
$16.44
$21.50

Technical Indicators

Market Signals
Indicator
CGAU
TXG
Relative Strength Index (RSI) 82.06 70.92
Support Level $15.68 $20.01
Resistance Level $16.44 $21.50
Average True Range (ATR) 0.56 1.33
MACD 0.16 0.34
Stochastic Oscillator 93.40 99.13

Price Performance

Historical Comparison
CGAU
TXG

About CGAU Centerra Gold Inc.

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: